NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
CURO Group Holdings Corp. (NYSE: CURO)
Class Period: July 31, 2018 - October 24, 2018
Lead Plaintiff Deadline: February 4, 2019
Join the action: https://www.zlk.com/pslra-1/curo-group-holdings-corp-loss-form?wire=3
The complaint alleges that throughout the class period Defendants materially misrepresented to investors the deleterious effect
that the up-front loan loss provisioning in connection with a transition of its Canadian inventory to Open-Ended loans was having
on the Company’s financial performance and 2018 full-year Company guidance. Because CURO’s Open-End Loans had a materially lower
lending yield than the Single-Pay Products, and the portfolio of Open-End Loans was still immature and unseasoned, the up-front
loan loss provisioning for these loans was far greater than publicly revealed (and the yield far lower). This caused the Company to
materially overstate its 2018 projected financial results, including CURO’s adjusted EBITDA, net revenue and operating
earnings.
To learn more about the CURO Group Holdings Corp. class action contact jlevi@levikorsinsky.com.
XPO Logistics, Inc. (NYSE: XPO)
Class Period: February 26, 2014 - December 12, 2018
Lead Plaintiff Deadline: February 12, 2019
Join the action: https://www.zlk.com/pslra-1/xpo-logistics-inc-loss-form?wire=3
The lawsuit alleges: XPO Logistics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i)
XPO’s highly touted aggressive M&A strategy had yielded only minimal returns to the Company; (ii) XPO was utilizing improper
accounting practices to mask its true financial condition, including, inter alia, under-reporting of bad debts and aggressive
amortization assumptions; and (iii) as a result, the Company’s public statements were materially false and misleading at all
relevant times.
To learn more about the XPO Logistics, Inc. class action contact jlevi@levikorsinsky.com.
Immunomedics, Inc. (NASDAQ: IMMU)
Class Period: August 23, 2018 - December 20, 2018
Lead Plaintiff Deadline: February 25, 2019
Join the action: https://www.zlk.com/pslra-1/immunomedics-inc-loss-form?wire=3
The complaint alleges that, throughout the class period, defendants made false and misleading statements. The United States Food
& Drug Administration issued citations against Immunomedics for multiple violations at its Morris Plains, New Jersey facility. The
FDA citations included the manipulation of bioburden samples, backdating of records, and misrepresentation of integrity test
procedures. Based on these facts, the Company’s public statements were false and materially misleading throughout the class
period. On December 17, 2018, FDAnews.com published an article entitled “FDA Hits Immunomedics for Data Integrity
Breach.” Upon this news, Immunomedics’ stock price fell sharply, damaging investors.
To learn more about the Immunomedics, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
